AFJK
Aimei Health Technology Co., Ltd (NASDAQ)
Financial Services — Shell Companies
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
None
$31.68
+$-3.89 (+4.55%)
Sign in to add AFJK to a watchlist or set price alerts.
Price History
Fundamentals
| Market Cap | $88.66M |
| P/E Ratio (TTM) | 186.67 |
| Forward P/E | - |
| EPS (TTM) | $0.15 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 38.0 |
| Beta | 0.23 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | - |
| 52-Week Low | - |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | - |
| Volume | - |
Performance Analysis
NEUTRALAFJK presents a mixed picture with both positive and negative indicators.
~
RSI at 38.0 is in neutral territory.
-
P/E of 186.7 is elevated — the market expects high growth or it may be overvalued.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 01, 2026 15:01 UTC
Back to Screener Export Report